Daxor Corporation (DXR) Balance Sheet

NASDAQ: DXRAssets, liabilities, debt and equity over 10 years.

DXR balance sheet, 2025

December 31, 2025 · U.S. dollars

$46.0M assets = $122,595 liabilities + $45.9M equity

What it owns$46.0MLT investments: $46.0M (100.0%)LT investments$46.0M · 100%Other non-current: $9,861 (0.0%)=How it is financed$46.0MCurrent liabilities: $122,595 (0.3%)Other LT liabilities: $122,595 (0.3%)Shareholders’ equity: $45.9M (99.7%)Shareholders’ equity$45.9M · 100%

Both columns are drawn to the same scale: what DXR owns equals what it owes plus shareholders’ equity. Hover a block for its value.

DXR financial health

Debt / equity0.00
Low leverage · $0.00 of debt for each $1 of equity
Equity / assets99.7%
Equity-funded · of assets funded by shareholders
Cash / debt0.0%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

DXR balance sheet trends, 2016–2025

Daxor Corporation balance sheet trends
MetricTrendThenLatestChange
Total assets$20.6M2016$46.0M2025+9.3%/yr
Total liabilities$5.3M2016$122,5952025−34.2%/yr
Shareholders’ equity$15.3M2016$45.9M2025+12.9%/yr
Cash & short-term investments$2.2M2016$710,7002021−20.1%/yr
Total debt$2.8M2016$112,0002025−30.1%/yr
Net cash (debt)−$617,8662016−$112,0002025+$505,866
Working capital$2.6M2016−$91,7622024−$2.7M
Book value per share$4.012016$9.202025+9.7%/yr
Debt / equity0.1820160.002025−0.18
Shares outstanding3.8M20165.0M2025+3.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

DXR assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

DXR liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

DXR debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

DXR balance sheet

Daxor Corporation annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments————$710,700$617,800——$1.1M$2.2M
Cash & equivalents————$710,700$617,800——$1.1M$2.2M
Receivables$0$9,678$14,198$17,233$30,700$29,298$32,738$33,710$45,269$45,873
Inventory$0$0$0$0$0$0$0$0$0$0
Other current assets—$8,890$11,684$20,606$23,097$0$0$3,014$0$389,270
Total current assets—$18,568$25,882$37,839$764,497$29,298$32,738$36,724$45,269$2.6M
Property, plant & equipment (net)$0$0$0$0$0$0$0$0$0$0
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$46.0M$36.6M$34.8M$30.2M$24.2M$15.7M$14.0M$17.2M$18.1M$18.0M
Other non-current assets$9,861$0$0$0$0$851,692$198,473$353,986$1.1M$33,182
Total assets$46.0M$36.6M$34.9M$30.3M$25.0M$16.6M$14.2M$17.6M$19.3M$20.6M
Liabilities
Accounts payable$112,000$110,330$103,099$62,436$87,400$80,000$78,750$72,500$75,000$7,818
Short-term debt————$715,800$627,000$1.3M$4.5M$4.3M$2.8M
Deferred revenue————−$628,400−$547,000——−$1.0M−$2.2M
Total current liabilities$122,595$110,330$103,099$62,436$806,425$707,000$78,750$72,500$75,000$7,818
Long-term debt$0$0$0$0$0$0$1.3M$4.5M$4.3M$2.8M
Other long-term liabilities$122,595$729,966$755,659$1.2M$3.0M$170,689$0$0$0$0
Total liabilities$122,595$840,296$858,758$1.3M$3.8M$877,689$1.4M$4.6M$5.6M$5.3M
Shareholders' equity
Common stock & paid-in capital$55,346$54,092$53,166$53,166$53,166$53,166$53,166$53,166$53,166$53,166
Retained earnings (deficit)$34.8M$25.6M$25.1M$24.8M$19.6M$14.9M$16.6M$17.1M$8.5M$10.4M
Treasury stock—————−$10.6M−$14.9M−$14.9M−$15.0M−$14.7M
Accumulated other comprehensive income$34.8M—$25.1M$24.8M$19.6M$14.9M$16.6M$17.1M——
Total shareholders' equity$45.9M$35.8M$34.0M$29.0M$21.2M$15.7M$12.8M$13.1M$13.8M$15.3M
Key figures
Total debt$112,000$729,966$755,659$1.2M$3.0M$170,689$1.3M$4.5M$4.3M$2.8M
Net cash (debt)−$112,000−$729,966−$755,659−$1.2M−$2.3M$447,111−$1.3M−$4.5M−$3.2M−$617,866
Working capital—−$91,762−$77,217−$24,597−$41,928−$677,702−$46,012−$35,776−$29,731$2.6M
Tangible book value$45.9M$35.8M$34.0M$29.0M$21.2M$15.7M$12.8M$13.1M$13.8M$15.3M
Book value per share$9.20$7.39$7.34$3.38$5.24$3.98$3.05$3.49$3.65$4.01
Shares outstanding5.0M4.8M4.6M8.6M4.0M3.9M4.2M3.7M3.8M3.8M
Current ratio—0.170.250.610.950.040.420.510.60335.00
Quick ratio0.000.090.140.280.920.920.420.4615.13285.21
Debt / equity0.000.020.020.040.140.010.110.340.320.18
Equity / assets99.7%97.7%97.5%95.7%84.7%94.7%89.9%74.1%71.2%74.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.

DXR financial position

At the end of fiscal 2025 (December 31, 2025), Daxor had total assets of $46.0 million (up 25.6% from a year earlier), total liabilities of $0.1 million and shareholders' equity of $45.9 million. It held $0 in cash and short-term investments against $0.1 million of debt, net debt of $0.1 million. In the latest quarter (ended June 30, 2026) total assets were $51.9 million and equity $51.8 million.

Related: DXR income statement, DXR cash flow statement, DXR key metrics. See the DXR stock overview for the latest quote and news.

DXR balance sheet FAQ

What are Daxor's total assets?

Daxor reported total assets of $46.0 million at the end of fiscal 2025 (December 31, 2025), compared with $36.6 million a year earlier.

How much debt does Daxor have?

Daxor had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.00.

What is Daxor's book value?

Daxor's shareholders' equity (book value) was $45.9 million at the end of fiscal 2025, or $9.20 per share.

Medical Instruments & Supplies: balance sheet